Phenotype
|
Fish
|
Conditions
|
Figures
|
eye melanocyte spatial pattern, abnormal
|
tapt1bcmg6/cmg6 (AB)
|
standard conditions
|
Fig. S4
from Jarayseh et al., 2023
|
eye iridophore spatial pattern, abnormal
|
tapt1bcmg6/cmg6 (AB)
|
standard conditions
|
Fig. S4
from Jarayseh et al., 2023
|
cranial cartilage malformed, abnormal
|
AB + CRISPR1-tapt1b
|
standard conditions
|
Fig. S13
from Symoens et al., 2015
|
ceratobranchial cartilage disorganized, abnormal
|
AB + CRISPR1-tapt1b
|
standard conditions
|
Fig. S13
from Symoens et al., 2015
|
ceratohyal cartilage disorganized, abnormal
|
AB + CRISPR1-tapt1b
|
standard conditions
|
Fig. S13
from Symoens et al., 2015
|
splanchnocranium immature, abnormal
|
AB + CRISPR1-tapt1b
|
standard conditions
|
Fig. S13
from Symoens et al., 2015
|
ceratobranchial cartilage chondrocyte absent, abnormal
|
hu5910Tg + CRISPR1-tapt1b
|
standard conditions
|
Fig. S13
from Symoens et al., 2015
|
cranial neural crest cell decreased amount, abnormal
|
y1Tg + CRISPR1-tapt1b
|
standard conditions
|
Fig. S13
from Symoens et al., 2015
|
cranial neural crest cell disorganized, abnormal
|
y1Tg + CRISPR1-tapt1b
|
standard conditions
|
Fig. S13
from Symoens et al., 2015
|
whole organism increased length, abnormal
|
tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB)
|
standard conditions
|
Fig. 2
from Jarayseh et al., 2023
|
kidney dorsal side increased pigmentation, abnormal
|
tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB)
|
standard conditions
|
Fig. 2
from Jarayseh et al., 2023
|
ciliary marginal zone ventral side decreased size, abnormal
|
tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB)
|
standard conditions
|
Fig. 4
from Jarayseh et al., 2023
|
swimming behavior process quality, abnormal
|
tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB)
|
standard conditions
|
Fig. 5
from Jarayseh et al., 2023
|
oral cavity dorsal side increased pigmentation, abnormal
|
tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB)
|
standard conditions
|
Fig. 2
from Jarayseh et al., 2023
|
swim bladder dorsal side increased pigmentation, abnormal
|
tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB)
|
standard conditions
|
Fig. 2
from Jarayseh et al., 2023
|
retina increased thickness, abnormal
|
tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB)
|
standard conditions
|
Fig. 4
from Jarayseh et al., 2023
|
anterior chamber eye collapsed, abnormal
|
tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB)
|
standard conditions
|
Fig. 4
from Jarayseh et al., 2023
|
retinal inner plexiform layer inclusion body present, abnormal
|
tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB)
|
standard conditions
|
Fig. 4
from Jarayseh et al., 2023
|
retinal ganglion cell layer hyperplastic, abnormal
|
tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB)
|
standard conditions
|
Fig. 4
from Jarayseh et al., 2023
|
pupil decreased area, abnormal
|
tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB)
|
standard conditions
|
Fig. 3
from Jarayseh et al., 2023
|
dorsal aorta dorsal side increased pigmentation, abnormal
|
tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB)
|
standard conditions
|
Fig. 2
from Jarayseh et al., 2023
|
retinal ganglion cell layer increased thickness, abnormal
|
tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB)
|
standard conditions
|
Fig. 4
from Jarayseh et al., 2023
|
eye melanocyte spatial pattern, abnormal
|
tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB)
|
standard conditions
|
Fig. 2
from Jarayseh et al., 2023
|
ciliary marginal zone dorsal side decreased size, abnormal
|
tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB)
|
standard conditions
|
Fig. 4
from Jarayseh et al., 2023
|
lens capsule delaminated, abnormal
|
tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB)
|
standard conditions
|
Fig. 4
from Jarayseh et al., 2023
|
photoreceptor outer segment layer degenerate, abnormal
|
tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB)
|
standard conditions
|
Fig. 4
from Jarayseh et al., 2023
|
retinal inner plexiform layer increased thickness, abnormal
|
tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB)
|
standard conditions
|
Fig. 4
from Jarayseh et al., 2023
|
lens decreased size, abnormal
|
tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB)
|
standard conditions
|
Fig. 4
from Jarayseh et al., 2023
|
whole organism opn1mw2 expression increased amount, abnormal
|
tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB)
|
standard conditions
|
Fig. 7
from Jarayseh et al., 2023
|
whole organism mipa expression decreased amount, abnormal
|
tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB)
|
standard conditions
|
Fig. 7
from Jarayseh et al., 2023
|
whole organism timp2b expression increased amount, abnormal
|
tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB)
|
standard conditions
|
Fig. 7
from Jarayseh et al., 2023
|
retinal inner plexiform layer hyperplastic, abnormal
|
tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB)
|
standard conditions
|
Fig. 4
from Jarayseh et al., 2023
|
integument increased pigmentation, abnormal
|
tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB)
|
standard conditions
|
Fig. 2
from Jarayseh et al., 2023
|
whole organism cryaa expression decreased amount, abnormal
|
tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB)
|
standard conditions
|
Fig. 7
from Jarayseh et al., 2023
|
whole organism dead, abnormal
|
tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB)
|
standard conditions
|
Fig. S2
from Jarayseh et al., 2023
|
lens cell mislocalised, abnormal
|
tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB)
|
standard conditions
|
Fig. 4
from Jarayseh et al., 2023
|
whole organism crygn1 expression decreased amount, abnormal
|
tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB)
|
standard conditions
|
Fig. 7
from Jarayseh et al., 2023
|
eye iridophore spatial pattern, abnormal
|
tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB)
|
standard conditions
|
Fig. 2
from Jarayseh et al., 2023
|
anterior chamber eye opacity, abnormal
|
tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB)
|
standard conditions
|
Fig. 4
from Jarayseh et al., 2023
|
vitreous absence of anatomical entity, abnormal
|
tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB)
|
standard conditions
|
Fig. 4
from Jarayseh et al., 2023
|
retinal pigmented epithelium low brightness, abnormal
|
tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB)
|
standard conditions
|
Fig. 4
from Jarayseh et al., 2023
|
eye decreased area, abnormal
|
tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB)
|
standard conditions
|
Fig. 3
from Jarayseh et al., 2023
|
lens position, abnormal
|
tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB)
|
standard conditions
|
Fig. 4
from Jarayseh et al., 2023
|
pupil decreased ratio eye, abnormal
|
tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB)
|
standard conditions
|
Fig. 3
from Jarayseh et al., 2023
|
optokinetic behavior decreased process quality, abnormal
|
tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB)
|
standard conditions
|
Fig. 5
from Jarayseh et al., 2023
|
whole organism col2a1a expression increased amount, abnormal
|
tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB)
|
standard conditions
|
Fig. 7
from Jarayseh et al., 2023
|
whole organism rom1a expression decreased amount, abnormal
|
tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB)
|
standard conditions
|
Fig. 7
from Jarayseh et al., 2023
|